首页> 外文期刊>JACC. Cardiovascular interventions >Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Validation of the logistic clinical syntax (synergy between percutaneous coronary interventions with taxus and cardiac surgery) score
【24h】

Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Validation of the logistic clinical syntax (synergy between percutaneous coronary interventions with taxus and cardiac surgery) score

机译:经皮冠状动脉介入治疗的急性冠状动脉综合征患者1年死亡率的预测:逻辑Logistic临床语法(紫杉类与心脏手术经皮冠状动脉介入治疗的协同作用)评分的验证

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives This study sought to validate the Logistic Clinical SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score in patients with non-ST-segment elevation acute coronary syndromes (ACS), in order to further legitimize its clinical application. Background The Logistic Clinical SYNTAX score allows for an individualized prediction of 1-year mortality in patients undergoing contemporary percutaneous coronary intervention. It is composed of a "Core" Model (anatomical SYNTAX score, age, creatinine clearance, and left ventricular ejection fraction), and "Extended" Model (composed of an additional 6 clinical variables), and has previously been cross validated in 7 contemporary stent trials (>6,000 patients). Methods One-year all-cause death was analyzed in 2,627 patients undergoing percutaneous coronary intervention from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. Mortality predictions from the Core and Extended Models were studied with respect to discrimination, that is, separation of those with and without 1-year all-cause death (assessed by the concordance [C] statistic), and calibration, that is, agreement between observed and predicted outcomes (assessed with validation plots). Decision curve analyses, which weight the harms (false positives) against benefits (true positives) of using a risk score to make mortality predictions, were undertaken to assess clinical usefulness. Results In the ACUITY trial, the median SYNTAX score was 9.0 (interquartile range 5.0 to 16.0); approximately 40% of patients had 3-vessel disease, 29% diabetes, and 85% underwent drug-eluting stent implantation. Validation plots confirmed agreement between observed and predicted mortality. The Core and Extended Models demonstrated substantial improvements in the discriminative ability for 1-year all-cause death compared with the anatomical SYNTAX score in isolation (C-statistics: SYNTAX score: 0.64, 95% confidence interval [CI]: 0.56 to 0.71; Core Model: 0.74, 95% CI: 0.66 to 0.79; Extended Model: 0.77, 95% CI: 0.70 to 0.83). Decision curve analyses confirmed the increasing ability to correctly identify patients who would die at 1 year with the Extended Model versus the Core Model versus the anatomical SYNTAX score, over a wide range of thresholds for mortality risk predictions. Conclusions Compared to the anatomical SYNTAX score alone, the Core and Extended Models of the Logistic Clinical SYNTAX score more accurately predicted individual 1-year mortality in patients presenting with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention. These findings support the clinical application of the Logistic Clinical SYNTAX score.
机译:目的本研究旨在验证非ST段抬高急性冠状动脉综合征(ACS)患者的Logistic临床SYNTAX(经皮冠状动脉介入治疗与红细胞和心脏手术的协同作用)评分,以进一步使其临床应用合法化。背景Logistic临床SYNTAX评分可对正在接受当代经皮冠状动脉介入治疗的患者的1年死亡率进行个性化预测。它由“核心”模型(解剖上的SYNTAX评分,年龄,肌酐清除率和左心室射血分数)和“扩展”模型(由另外的6个临床变量组成)组成,并且先前已在7个当代模型中进行了交叉验证。支架试验(> 6,000名患者)。方法对2627例接受ACUITY(急性导管插入和紧急干预分类策略)经皮冠状动脉介入治疗的患者的一年全因死亡进行了分析。根据核心模型和扩展模型的死亡率预测,研究了歧视问题,即将有和没有1年全因死亡的人分开(由一致性[C]统计数据评估),并进行校正,即观察和预测的结果(通过验证图进行评估)。进行决策曲线分析,以权衡使用风险评分进行死亡率预测的危害(假阳性)与收益(真阳性)之间的权衡,以评估临床有效性。结果在ACUITY试验中,SYNTAX的中位数为9.0(四分位间距为5.0到16.0)。大约40%的患者患有3支血管疾病,29%的糖尿病和85%的患者接受了药物洗脱支架植入。验证图证实了观察到的和预测的死亡率之间的一致性。与孤立的解剖SYNTAX评分相比,核心模型和扩展模型证明了1年全因死亡的判别能力有了显着提高(C统计:SYNTAX评分:0.64,95%置信区间[CI]:0.56至0.71;核心模型:0.74,95%CI:0.66至0.79;扩展模型:0.77,95%CI:0.70至0.83)。决策曲线分析证实,在广泛的死亡风险预测阈值范围内,通过扩展模型,核心模型和解剖SYNTAX评分,能够正确识别在1年后死亡的患者的能力不断增强。结论与单独的SYNTAX解剖评分相比,Logistic临床SYNTAX评分的核心模型和扩展模型可以更准确地预测接受经皮冠状动脉介入治疗的非ST段抬高急性冠脉综合征患者的1年死亡率。这些发现支持了Logistic Clinical SYNTAX评分的临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号